PAG
TXG icon

Private Advisor Group’s 10x Genomics TXG Stock Holding History

Private Advisor Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-66,993
Closed -$1.09M – 2849
2025
Q4 		$1.09M Buy
+66,993
New +$1.01M 0.01% 1360
2021
Q3 		– Sell
-1,538
Closed -$301K – 2095
2021
Q2 		$301K Buy
1,538
+60
+4% +$10.9K ﹤0.01% 1629
2021
Q1 		$268K Buy
+1,478
New +$255K ﹤0.01% 1605
2020
Q3 		– Sell
-14
Closed -$1K – 3296
2020
Q2 		$1K Buy
+14
New +$1.09K ﹤0.01% 3762

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Advisor Group's TXG Position: Q1 2026 in Review

Private Advisor Group sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 66,993 shares — an estimated $1.09M sold.

Private Advisor Group first reported a position in TXG in Q2 2020 and held it in 4 quarters. The position peaked at $1.09M in Q4 2025. 331 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Private Advisor Group reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Private Advisor Group sold 66,993 10x Genomics shares in Q1 2026, an estimated $1.09M.
  • Private Advisor Group first reported a position in 10x Genomics in Q2 2020 and held it in 4 quarters.
  • Private Advisor Group's 10x Genomics position peaked at $1.09M in Q4 2025.
  • 331 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.